High prevalence of NSAID enteropathy as shown by a simple faecal test

Gut

Volumn 45, Issue 3, 1999, Pages 362-366

  Tibble, J A ^a   Sigthorsson, G ^a   Foster, R ^a   Scott, D ^a   Fagerhol, M K ^b   Roseth, A ^c   Bjarnason, I ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Calprotectin; Enteropathy; Non steroidal anti inflammatory drug

Indexed keywords

CALPROTECTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; DRUG EFFECT; ENTEROPATHY; FECES ANALYSIS; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; OSTEOARTHRITIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN CONTENT; RHEUMATOID ARTHRITIS; STOMACH EROSION; STOMACH MUCOSA;

EID: 0032786449     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.45.3.362     Document Type: Article

References (33)

1. 1 Beardon PH, Brown SV, McDevitt DG. Gastrointestinal events in patients prescribed non-steroidal anti-inflammatory drugs: a controlled study using record linkage in Tayside. Q J Med 1989;71:197-505.
2. 2 Armstrong CP, Blower AL. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut 1987;28:527-32.
3. 3 Singh G, Rosen Ramey D. NSAID induced gastrointestinal complications: the ARAMIS perspective 1997. Arthritis, rheumatism, and aging medical information system. J Rheumatol Suppl 1998;51:8-16.
4. 4 Morris AJ, Wasson LA, MacKenzie JF. Small bowel enteroscopy in undiagnosed gastrointestinal blood loss. Gut 1992; 33:887-9.
5. 5 Allison MC, Howatson AG, Torrance CJ, et al. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med 1992;327:749-54.
6. 6 Bjarnason I, Williams P, So A, et al. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet 1984;ii: 1171-4.
7. 7 Bjarnason I, Zanelli G, Prouse P, et al. Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs. Lancet 1987;ii:711-14.
8. 8 Morris AJ, Murray L, Sturrock RD, et al. Short report: the effect of misoprostol on the anaemia of NSAID enteropathy. Aliment Pharmacol Ther 1994;8:343-6.
9. 9 Collins AJ, Du Toit JA. Upper gastrointestinal findings and faecal occult blood in patients with rheumatic diseases taking nonsteroidal anti-inflammatory drugs. Br J Rheumatol 1987;26:295-8.
10. 10 Hedenbro JL, Wetterberg P, Vallgren S, et al. Lack of correlation between fecal blood loss and drug-induced gastric mucosal lesions. Gastrointest Endosc 1988;34:247-51.
11. 11 Levi S, de Lacey G, Price AB, et al. "Diaphragm-like" strictures of the small bowel in patients treated with non-steroidal anti-inflammatory drugs. Br J Radiol 1990; 63:186-9.
12. 12 Kwo PY, Tremaine WJ. Nonsteroidal anti-inflammatory drug-induced enteropathy: case discussion and review of the literature. Mayo Clin Proc 1995;70:55-61.
13. 13 Langman MJ, Morgan L, Worrall A. Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. Br Med J Clin Res Ed 1985;290:347-9.
14. 14 Morris AJ, MacKenzie JF. Small-bowel enteroscopy and NSAID ulceration. Lancet 1991;337:1550.
15. 15 Dale I, Brandtzaeg P, Fagerhol MK, et al. Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. Am J Clin Pathol 1985;84:24-34.
16. 16 Fagerhol MK AT, Naess-Andresen CF, Brandtzaeg P, et al. Calprotectin (the L1 leukocyte protein). In: Vana L, Dedman SJ, eds. Stimulus response coupling: the role of intracellular calcium-binding proteins. Boca Raton, Florida: CRC Press Inc., 1990:187-210.
17. 17 Roseth AG, Fagerhol MK, Aadland E, et al. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 1992;27:793-8.
18. 18 Roseth AG, Aadland E, Jahnsen J, et al. Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion 1997;58:176 80.
19. 19 Teahon K RA, Foster R, Bjarnason I. Faecal calprotectin: a simple sensitive quantitative measure of intestinal inflammation in man [abstract]. Gastroenterology 1997; 112(suppl):A1103.
20. 20 Bjarnason I, Hayllar J, Smethurst P, et al. Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy. Gut 1992;33:1204-8.
21. 21 Hayllar J, Smith T, Macpherson A, et al. Nonsteroidal anti-inflammatory drug-induced small intestinal inflammation and blood loss. Effects of sulfasalazine and other disease-modifying antirheumatic drugs. Arthritis Rheum 1994;37: 1146-50.
22. 22 Bjarnason I, Macpherson A. Treatment of nonsteroidal antiinflammatory drug induced damage to the small and large intestine. In: Bayless T, ed. Current therapy in gastroenterology and liver disease. 4th edn. St Louis: Mosby, 1994:295-8.
23. 23 Bjarnason I, Zanelli G, Smith T, et al. Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology 1987;93:180-9.
24. 24 Teahon K, Bjarnason I. Comparison of leucocyte excretion and blood loss in inflammatory disease of the bowel. Gut 1993;34:1535-8.
25. 25 Segal AW, Isenberg DA, Hajirousou V, et al. Preliminary evidence for gut involvement in the pathogenesis of rheumatoid arthritis? Br J Rheumatol 1986;25:162-6.
26. 26 Bjarnason I, Williams P, Smethurst P, et al. Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut 1986;27:1292-7.
27. 27 Jenkins RT, Rooney PJ, Jones DB et al. Increased intestinal permeability in patients with rheumatoid arthritis: a side-effect of oral nonsteroidal anti-inflammatory drug therapy? Br J Rheumatol 1987;26:103-7.
28. 28 Meling TR, Aabakken L, Roseth A, et al. Faecal calprotectin shedding after short-term treatment with non-steroidal anti-inflammatory drugs. Scand J Gastroenterol 1996;31: 339-44.
29. 29 Loser C, Mollgaard A, Folsch U. Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. Gut 1996;39:580-6.
30. 30 Bjarnason I, Fehilly B, Smethurst P, et al. Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man. Gut 1991;32:275-7.
31. 31 Somasundaram S, Hayllar H, Rafi S, et al. The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: a review and a hypothesis. Scand J Gastroenterol 1995;30:289-99.
32. 32 Mielants H VE, Cuvalier C, De Vos M. Ileocolonoscopic findings in seronegative spondylarthropathies. Br J Rheumatol 1988;27(suppl II):95-105.
33. 33 Levi S, Shaw Smith C. Non-steroidal anti-inflammatory drugs: how do they damage the gut? Br J Rheumatol 1994; 33:605-12.